Navigation Links
Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Date:10/25/2007

30, 2007 31, 2006

(unaudited)

Assets

Current assets:

Cash and cash equivalents $19,568 $14,249

Short-term investments 1,298 28,160

Receivables 219 242

Prepaid expenses and other current assets 873 608

Total current assets 21,958 43,259

Property and equipment, net 34,148 25,071

Restricted cash 3,451 3,451

Other assets 487 508

Total assets $60,044 $72,289

Liabilities and stockholders' equity

Current liabilities:

Accounts payable and accrued liabilities $4,964 $6,779

Current portion of debt 5,767 4,976

Total current liabilities 10,731 11,755

Debt, less current portion 7,576 5,754

Deferred rent 15,179 10,145

Commitments and contingencies

Stockholders' equity:

Preferred stock, $0.001 par value

5,000,000 shares authorized at September 30,

2007 and December 31, 2006; no shares

issued and outstanding at September 30,

2007 and December 31, 2006 - -

Common stock, $0.001 par value:

Authorized shares, 75,000,000 at

September 30, 2007 and December 31, 2006;

Issued and outstanding shares- 33,753,206

and 29,060,081 at September 30, 2007 and

December 31, 2006, respectively 34 29

Additional paid-in capital
'/>"/>

SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
2. Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
5. XTL Provides Update on Phase I Clinical Trial of XTL-2125
6. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
7. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
8. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
9. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
10. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
11. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... CLEVELAND , Jan. 14, 2014 NineSigma ... will hold its Innovation Leadership Summit , May ... in Cleveland Ohio . ... innovators and organizations committed to breakthrough achievements through open ...
(Date:1/14/2014)... , January 14, 2014 ... Transfer Devices (CSTD) for hazardous drugs, today announced that it ... fourth straight year.   Equashield,s closed ... technicians, pharmacists, nurses and other medical professionals who ...
(Date:1/14/2014)... Spark Therapeutics , a late-stage gene therapy company, has reached ... Phase 3 study for inherited retinal dystrophies caused by mutations in ... , is presenting this and other corporate updates today, at the ... . Marrazzo said Spark was able to achieve its recruitment ...
Breaking Medicine Technology:Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 3
(Date:4/23/2014)... identified an important enzyme pathway that helps prevent new ... a condition that has been directly linked to cancer ... biochemistry, found that near the end of cell division, ... any breaks in DNA are fully repaired before the ... cells. This process helps safeguard against some of the ...
(Date:4/23/2014)... methods that can rapidly screen a large cell ... inside that population has been seriously lacking," said ... the Royal Society of Chemistry journal Chemical ... his coworkers have developed a novel technique that ... Chem. Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ...
(Date:4/23/2014)... 2014 Five for-profit and non-profit organizations in ... in Proof of Concept grants to accelerate maturation ... products, the Life Sciences Discovery Fund (LSDF) announced ... Program grant to the Washington Biotechnology & Biomedical ... to train the next generation of entrepreneurs and ...
(Date:4/23/2014)... depletion of self-control, according to research published in ... Psychological Science. , Self-control can be difficult sticking ... a boring textbook are hard things to do. Considerable ... self-control for a long period seems to "deplete" our ... "It is as if self-control is a limited resource ...
(Date:4/22/2014)... been shown to reduce seizures in patients with medication-resistant ... with an innovative electrode placement planning system developed by ... of seizures in nearly half of the implanted Rush ... good news for a large portion of the nearly ... seizures can,t be controlled with medications and who are ...
Breaking Medicine News(10 mins):Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:ADHD drug may help preserve our self-control resources 2Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2
... helping teenagers manage the stress involved in condom use is ... The study conducted by lead author Celia Lescano of the ... School of Brown University in Providence, R.I., was based on ... ,Lescano found that lack of self-efficacy (the belief ...
... States, are now spreading their wings with distant shores in ... clinic will be set up at Tokyo, Japan. ... growing discontent with the national health-care system. Accordingly, around 40 ... caring for an aging population. This has even got to ...
... hepatitis B virus (HBV) transmission between two patients at a ... infection is exceedingly rare, universal vaccination against the virus would ... ,The case report, by John T. Redd, ... and Prevention (CDC) and the New Mexico Department of Health, ...
... has assured assistance to doctors of Indian origin who are ... in London due to changes in immigration rules. // ... changes that make it difficult for non-European Union doctors to ... April 2006, and have since been the subject of litigation. ...
... for acceptable cholesterol levels were lowered causing widespread concern ... quoted in the British Medical Journal stated that the ... be put on high-dose statins. Researchers say they are ... because there is too little research on outcomes. ...
... who report in with a head injury are twice as likely ... who sprain their ankle or wrist, instead. , Says Dr. ... published in the journal Pediatrics: “They were almost twice as likely ... had a sprained ankle or wrist." , The researchers ...
Cached Medicine News:Health News:John Hopkins Hospitals- Now at Tokyo 2Health News:Rare Case of Hepatitis B Virus Transmission Between Dental Patients Recorded 2Health News:Rare Case of Hepatitis B Virus Transmission Between Dental Patients Recorded 3Health News:India Assures Help to Doctors of Indian Origin 2Health News:Revised Cholesterol Guidelines Causes Concern Among Medical Community 2Health News:When ‘Humpty Dumpty’ Falls Aga 2
... Ankle Cryo/Cuff combines the therapeutic benefits of ... and cold to minimize pain. The cuff ... ankle providing maximum cryotherapy. The Ankle Cryo/Cuff ... available in a pediatric size.,All Cryo/Cuffs can ...
... The Air-Stirrup Plus combines the ... an ankle wrap. In addition, a ... each Air-Stirrup Plus and provides information ... components of ankle sprain management.,Each Air-Stirrup ...
... Aircast VenaFlow System (a prophylaxis for DVT), ... styles: calf, foot, and thigh, to suit ... from light, cool, comfortable material to promote ... be placed directly against the skin. With ...
Comfor™ Cast Boot - Rocker Sole - Closed Toe...
Medicine Products: